metagenomics
Cancer Immunotherapy Response Linked to Gut Microbes in Multiomic Analysis
Researchers found gut microbes and metabolites linked to pan-cancer immune checkpoint blockade responses, highlighting five distinct enterotypes.
Wellcome Sanger Institute, Open Targets Fund Inflammatory Bowel Disease Biomarker Study
Researchers will analyze multiomic and clinical data from 1,000 patients with IBD recruited from seven participating hospitals in the UK.
Mainz Biomed, Microba Life Sciences Partner to Develop Pancreatic Cancer Screening Test
The partners will collaborate to develop novel microbiome biomarkers for a screening test in development called PancAlert.
At ASCO, Biomarker Strategies Show Potential for Guiding Metastatic Pancreatic Cancer Treatment
Premium
Two studies presented Friday suggested that biomarker-selected approaches could improve patient outcomes on immunotherapy and targeted therapy.
Microbiotica Advancing Bacterial Signature to Improve Immunotherapy Response, Patient Selection
Premium
The firm is developing an oral capsule of live bacteria to improve response rates to checkpoint inhibitors and advancing a predictive test relying on the same bacterial signature.